Navigation path

Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information

Temocillin sodium

EU orphan designation number: EU/3/03/183   
Active ingredient: Temocillin sodium
Indication: Treatment of Burkholderia cepacia lung infection in cystic fibrosis
Sponsor: Eumedica N.V.
Avenue Winston Churchill 67, 1180 Brussels, Belgique/België

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/01/2004 Orphan designation EMEA/OD/028/03 (2004)85 of 14/01/2004
30/10/2012 Change of name and/or address of sponsor EMEA/OD/028/03
23/05/2014 Transfer of orphan designation EMEA/OD/028/03/T/01 (2014)3456 of 20/05/2014